These graphs compare the performance of the biotech stocks for all of 2025 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2025.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Axsome, Corcept, Mabwell, Ultragenyx, Vanda.

Biopharma happenings, including deals and partnerships, and other news in brief: Arbormed, Bioatla, Gatc, Emmaus, Hyloris, Neoimmunetech, Novo Nordisk.

Biopharmas raising money in public or private financings, including: Cybin, Insilico.

Biopharma money raised to-date and by month in 2025, including public, private and other financings.

New hires and promotions in the med-tech industry, including: Evotec, Shine.

Med-tech firms raising money in public or private financings, including: INBS.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Delcath Systems.